Live Breaking News & Updates on Halozyme First Quarter

Stay updated with breaking news from Halozyme first quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Roche Tecentriq , Vikram Purohit , Michael Difiore , Nicole Labrosse , Demyelinating Polyradiculoneuropathy , Helen Torley , Johnson Amivantamab , Bristol Myers Squibb Nivolumab , Jessica Fye , European Commission , Corporate Communications , American Academy Of Neurology Annual Meeting , Morgan Stanley , Halozyme Therapeutics Inc , Bristol Myers Squibb , Halozyme Therapeutics , Call Transcript May , Halozyme First Quarter , Operating Results Conference , Tram Building , Vice President , Investor Relations , Chief Executive Officer , Chief Financial Officer ,

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, my name is Chris and I ll be your conference operator today. ....

United States , Roche Phesgo , David Risinger , Eun Yang , Jessica Fye , Helen Torley , Nicole Labrosse , Michael Difiore , Caroline Palomeque , Mohit Bansal , Corinne Jenkins , Jason Butler , Wells Fargo , Halozyme Therapeutics Inc , European Medical Agency , Antares Pharma , Corporate Communications , Goldman Sachs , Halozyme Therapeutics , Call Transcript May , Halozyme First Quarter , Operating Results Conference , Tram Bui , Vice President , Investor Relations , First Quarter ,

Halozyme Therapeutics Inc (HALO) Q1 2021 Earnings Call Transcript

Halozyme Therapeutics Inc (HALO) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Halozyme Therapeutics Inc (NASDAQ: HALO)
Q1 2021 Earnings Call
Operator
Good day, and thank you for standing by. Welcome to the Halozyme First Quarter 2021 Financial Results Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Al Kildani, Vice President of Investor Relations and Corporate Communications. Thank you. Please go ahead.SPONSORED:
10 stocks we like better than Halozyme Therapeutics
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

Anita Dushyanth Berenberg , Joe Catanzaro , Roy Buchanan , Graig Suvannavejh , Jessica Fye , Joe Catanzaro Piper Sandler , Herceptin Hylecta , Helen Torley , Takeda Hyqvia , Al Kildani , Jason Butler , Roche Tecentriq , Piper Sandler , Bristol Myers Squibb , Elaine Sun , Roche Atezolizumab , Roche Phesgo , Anita Dushyanth , Graig Suvannavejh Goldman Sachs , Development Agreement , Motley Fool Halozyme Therapeutics Inc , National Institute Of Health , National Institute Of Allergy , Goldman Sachs , Halozyme Therapeutics Inc , Japan Ministry Of Health ,